FMC Corp (FMC.N)
74.98USD
22 Mar 2019
$-2.63 (-3.39%)
$77.61
$76.83
$77.00
$74.96
227,158
310,428
$92.95
$69.39
About
Overall
| Beta: | 1.62 |
| Market Cap(Mil.): | $12,227.14 |
| Shares Outstanding(Mil.): | 134.13 |
| Dividend: | 0.17 |
| Yield (%): | 0.72 |
Financials
| FMC.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 58.63 | 15.14 | 325.78 |
| EPS (TTM): | 1.55 | -- | -- |
| ROI: | 4.54 | 7.39 | 10.51 |
| ROE: | 10.44 | 11.61 | 13.69 |
UPDATE 1-Lithium-producer Livent says FMC sale to bring certainty for staff, investors
Nov 6 Lithium producer Livent Corp says majority owner FMC Corp's decision to sell its entire stake by next spring will help it better compete in the fast-moving sector, Chief Executive Paul Graves said on Tuesday.
Livent sees FMC exit as bringing 'more certainty' to operations
Nov 6 Livent Corp sees majority owner FMC Corp's decision to sell its entire stake by next spring as a step that will help it better compete in the fast-moving lithium market, the company's chief executive said on Tuesday.
UPDATE 1-Livent profit fails to beat expectations; shares drop
Nov 5 Livent Corp, the lithium producer spun off last month from FMC Corp, cut its 2018 sales forecast and posted a quarterly profit on Monday that failed to exceed Wall Street's expectations, sending its shares down nearly 4 percent in after-hours trading.
Livent quarterly profit jumps 18 percent on rising lithium demand
Nov 5 Livent Corp, the lithium producer spun off last month from FMC Corp, said on Monday its quarterly profit rose 18 percent due to rising demand for the white metal, a key component of electric car batteries.
UPDATE 2-Fresenius Medical Care says expects weaker growth in Q4
* Deadline for NxStage Medical takeover extended (Adds share price, analyst)
Estimates